| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,255 |
6,263 |
$334K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,781 |
1,546 |
$131K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,388 |
1,240 |
$73K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
504 |
459 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
481 |
440 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,341 |
1,210 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
323 |
233 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
127 |
109 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
43 |
43 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
14 |
$310.07 |
| 81003 |
|
44 |
38 |
$65.04 |
| 85027 |
|
12 |
12 |
$24.42 |
| 3008F |
|
336 |
309 |
$0.00 |
| 1036F |
|
222 |
207 |
$0.00 |
| 3074F |
|
270 |
257 |
$0.00 |
| 3079F |
|
15 |
14 |
$0.00 |
| 1159F |
|
455 |
423 |
$0.00 |
| 1160F |
|
455 |
423 |
$0.00 |
| 3078F |
|
202 |
192 |
$0.00 |